Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Pecs – page 7

346 clinical trials in Pecs, Hungary across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Pecs at a glance
346
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

346 trials in Pecs

Open in trial search
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:Pfizer Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Merck Sharp & Dohme LLC
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Rilzabrutinib
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Janssen Cilag International
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Abrocitinib
  • Sponsor:Pfizer Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Graves' disease

Recruiting
Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:IMEROPRUBART
  • Sponsor:Immunovant Sciences GmbH

Asthma

Recruiting
Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:AstraZeneca AB
Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Other cities in Hungary

The busiest research cities in the country

All 70 cities in Hungary

Clinical research in Pecs

What the registry says about research in the country

01 Respiratory Conditions

Clinical research focusing on innovative treatments for chronic rhinosinusitis and asthma, with studies evaluating new therapeutic approaches for both conditions with and without nasal polyps.

  • Uncontrolled Asthma Management
  • Nasal Polyps Treatment
  • Viral Lung Infections

Multiple trials investigating novel medications to improve respiratory symptoms and patient quality of life.

02 Cardiovascular Research

Groundbreaking studies in heart failure prevention and cardiomyopathy, exploring new therapeutic options for various cardiovascular conditions.

  • Heart Failure Risk Reduction
  • Hypertrophic Cardiomyopathy
  • Cardiovascular Disease Prevention

Advanced research aimed at reducing cardiovascular events and improving patient outcomes.

03 Autoimmune Disorders

Innovative research into treatments for systemic sclerosis and Sjögren's syndrome, focusing on novel therapeutic approaches for these challenging conditions.

  • Systemic Sclerosis Management
  • Primary Sjögren's Disease
  • Autoimmune Manifestations

Studies evaluating new biological treatments to address various autoimmune conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.